NRGN and Alzheimer disease: Among other results, we demonstrate a statistically significant correlation between CSF PINK1 and AD biomarkers, including a lower Aβ42/40 ratio and higher p-MAPT/tau (181), t-MAPT/tau, NEFL, and NRGN.